SpacePharma

Science Times - Cancer Drug Launched in Space via Falcon 9 Launcher: Doxil Nanotech Treatment Tested for Occurrence of Change in Zero Gravity Conditions

Cancer Drug Launched in Space via Falcon 9 Launcher: Doxil Nanotech Treatment Tested for Occurrence of Change in Zero Gravity Conditions

Medicine & Technology Dec 28, 2021

Drug cancer cell treatment, Doxil, manufactured by Ayana Pharma, was launched a week ago, to the International Space Station, as part of the mission of SpaceX.

SpacePharma

Cancer Drug Launched in Space via Falcon 9 Launcher: Doxil Nanotech Treatment Tested for Occurrence of Change in Zero Gravity Conditions

Most Popular

Sports Supplements For Brain Health? Creatinine May Improve Cognitive Ability Among the Sleep-Deprived, Study Reveals

Earth's Magnetic Field Nearly Collapsed 600 Million Years Ago, Sparking Evolution of More Complex Life

'Ugliest Man' With Physical Deformity Finds Love Three Times; What Is Fibrodysplasia Ossificans Progressiva (FOP)?

Extremely Powerful Solar Flare Unleashed by the Sun Triggered Widespread Radio Blackouts Across the Pacific Region

Functional Human Brain Cells Made From Salt and Water Mark Significant Step in Iontronic Neuromorphic Computing

Recommended Stories

Is Mars Like Earth? NASA Rover Finds Substantial Amounts of Manganese on the Red Planet's Gale Crater

‘Cosmic Glitch’ in Einstein’s Theory of General Relativity Could Be Explained in This New Scientific Tweak [Study]

Unique Exoplanet Found Lurking in Habitable Zone of 2 Stars

Eta Aquarids 2024: Halley's Comet Meteor Shower To Peak This Weekend; Here's How To Watch the Cosmic Light Show